Nootropil (Piracetam)

Piracetam enhances neuronal membrane fluidity and modulates AMPA‑type glutamate receptors, which promotes neuroplasticity and more efficient synaptic transmission. By improving oxygen and glucose utilization, it helps maintain neuronal health and supports cognitive processes across various neurological conditions.

The dosage of Nootropil is determined by the prescribing clinician based on the individual’s medical condition, age, renal and hepatic function, and response to therapy. Healthcare professionals tailor the regimen to achieve the desired therapeutic effect while minimizing potential adverse reactions.

Safety data for piracetam in pregnancy and lactation are limited. It should be avoided unless the potential benefits to the mother clearly outweigh any possible risks to the fetus or infant. Clinicians must evaluate each case individually and discuss alternatives when appropriate.

To request Nootropil, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details, and any necessary import documentation.

Piracetam belongs to the racetam class, which differs from other cognitive enhancers such as cholinesterase inhibitors or NMDA antagonists. While racetams primarily improve membrane fluidity and synaptic transmission, other agents may target neurotransmitter metabolism or receptor modulation. The choice depends on the specific clinical scenario and physician assessment.

Nootropil should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Nootropil is taken orally, typically as a tablet or capsule, with or without food as directed by the prescriber. The exact administration schedule, including timing and any dose adjustments, should follow the healthcare professional’s instructions.

Serious adverse reactions, though rare, can include severe skin rashes, allergic reactions such as anaphylaxis, blood disorders like leukopenia, and seizures in susceptible individuals. Patients should seek immediate medical attention if they experience any signs of these conditions.

Nootropil is contraindicated in individuals with known hypersensitivity to piracetam or any excipients in the formulation. Caution is advised for patients with severe renal or hepatic impairment, uncontrolled epilepsy, or those taking medications that may interact significantly, such as anticoagulants or anticonvulsants.